U.S. FDA rejects accelerated approval for Alzheimer’s drug, but Eli Lilly expects traditional approval later this year
Eli Lilly and Co on Thursday said the U.S. Food and Drug Administration has rejected accelerated approval of its experimental Alzheimer’s drug because it did not submit enough trial data from patients who were treated for at least 12 months.
Lilly said the FDA sent it a complete response letter for donanemab, an antibody designed to remove amyloid protein plaques from the brains of people with early Alzheimer’s. Such letters typically outline concerns and conditions that must be addressed to gain U.S. approval. Lilly said the FDA issued the letter “due to the limited number of patients with at least 12 months of drug exposure data provided in the submission.”
The company said it remained on track to report in the second quarter of this year results from a confirmatory Phase 3 trial of donanemab. That study, Lilly said, will form the basis of donanemab’s application for traditional FDA approval shortly thereafter.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The Daily Chase: Regulators approve BMO-Bank of the West takeover; Price of oil climbs - BNN BloombergBank of Montreal is getting the green light for its US$16.3 billion acquisition of Bank of the West, clearing the final regulatory approval for its major U.S. expansion.
Read more »
U.S. Fed approves BMO's US$16.3B Bank of the West takeover - BNN BloombergBank of Montreal has received approval from the the Federal Reserve to acquire San Francisco-based Bank of the West, a combination that will create the 15th-largest U.S. lender.
Read more »
Drug dealers still control 33 per cent of Canada's cannabis market despite legalizationFive years after Ottawa legalized marijuana, 33% of the market is still controlled by drug dealers, says the Department of Public Safety.
Read more »
Drug dealers still control 33% of Canada's cannabis market despite legalizationFive years after Ottawa legalized marijuana, 33% of the market is still controlled by drug dealers, says the Department of Public Safety.
Read more »
Drug dealers still control 33% of Canada's cannabis market despite legalizationFive years after Ottawa legalized marijuana, 33% of the market is still controlled by drug dealers, says the Department of Public Safety.
Read more »
Toronto woman says Shoppers Drug Mart sold her fake Apple AirPods and she's not aloneA woman from Toronto has alleged that a pair of Apple AirPods Pro she bought from Shoppers Drug Mart turned out to be fake, and the Loblaw Companie...
Read more »